Topical cyclosporine A therapy for dry eye syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topical Cyclosporine a Therapy for Dry Eye Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432235/all/Topical_cyclosporine_A_therapy_for_dry_eye_syndrome.
Topical cyclosporine A therapy for dry eye syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432235/all/Topical_cyclosporine_A_therapy_for_dry_eye_syndrome. Accessed January 19, 2025.
Topical cyclosporine A therapy for dry eye syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432235/all/Topical_cyclosporine_A_therapy_for_dry_eye_syndrome
Topical Cyclosporine a Therapy for Dry Eye Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432235/all/Topical_cyclosporine_A_therapy_for_dry_eye_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topical cyclosporine A therapy for dry eye syndrome
ID - 432235
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432235/all/Topical_cyclosporine_A_therapy_for_dry_eye_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -